KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
56 hedge funds and large institutions have $97.9M invested in Kindred Biosciences, Inc. in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
–
Holders Change %
0%
% of All Funds
1.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
27
Reduced
13
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jennison Associates
New York
|
$20.7M |
| 2 |
Morgan Stanley
New York
|
$3.58M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
$3.24M |
| 4 |
BG
Baupost Group
Boston,
Massachusetts
|
$27.9M |
| 5 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
$3.61M |
